Exosomes Early Promise
While exosome therapy is a burgeoning field, there are currently no FDA approved exosome treatments as more studies are needed to confirm the safety and efficacy of such products.
Expanded Access
Expanded access is an FDA program that under certain conditions allows the use of an investigational new drug (IND) to treat a patient with a serious or life-threatening disease outside of a clinical trial.
Eligibility for Right to Try
The Right to Try Act provides a new channel for eligible patients to request access to investigational drugs outside of their ongoing clinical trial.
Stem Cell Therapy: The Right to Try Act
The Right to Try Act allows patients access to treatments that are in the FDA’s drug approval pipeline but not yet approved.
Stem Cells and Anti-Aging
As the science of aging expands its knowledge of all the changes and challenges of aging, the use of stem cells for anti-aging will become one of the standards of care.
Who Named Mesenchymal Stem Cells?
Over thirty years ago Dr. Arnold Caplan coined the term MSCs and since then there have been thousands of clinical trials involving the use of adult stem cells.
Cellular Interventions: Current and Future Stem Cell Treatments
There are a number of cellular interventions that are currently being studied for the treatment of various diseases.
Stem cells promise of rejuvenation and repair
It has been demonstrated that stem cells have the ability to heal as well as rejuvenate and repair damage from a wide array of genetic and environmental conditions.
Bank your cultured stem cells or fat tissue now for your future health
Personalized Stem Cells offers multiple options to store your stem cells or fat tissue in our cGMP facility.
The Jury is Still Out on Exosomes
Though exosomes have shown some promise in the treatment of various diseases, more research is needed to determine the safety and efficacy of these products.